the study used data of 1,082 ct scans of stroke patients across 70 hospitals in britain.
..
.
.
why novartis� landmark cancer drug approval is great news for bluebird
.
the uk�s initial plan had been challenged in court by the
.-related side effects. its manufacturer, eli lilly, plans to submit a new drug application to the fda in the second half of 2018.
.
"there is an issue that needs to be addressed in terms of the narrative the health trust tried to present and mislead the inquest and cover up what actually happened.
.